首页> 美国卫生研究院文献>Oxford Open >2568. Mechanisms of a Specific Probiotic Comprised of Lactobacillus acidophilus CL1285 L. casei LBC80R and L. rhamnosus CLR2 that Interferes with Clostridioides difficile 20291 Toxin Production
【2h】

2568. Mechanisms of a Specific Probiotic Comprised of Lactobacillus acidophilus CL1285 L. casei LBC80R and L. rhamnosus CLR2 that Interferes with Clostridioides difficile 20291 Toxin Production

机译:2568.包括嗜酸乳杆菌CL1285干酪乳杆菌LBC80R和鼠李糖乳杆菌CLR2的特定益生菌干扰艰难梭菌20291毒素产生的机理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background Clostridioides difficile infections (CDI) result from antibiotic use and cause severe diarrhea (C. difficile-associated diarrhea, CDAD) which is life-threatening and costly. A specific probiotic containing Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 (Bio-K+) has demonstrated benefits in preventing CDI and has a strong inhibitory effect on the growth of several nosocomial C. difficile strains in vitro. Many Lactobacilli can inhibit CD growth though lactic acidification. Here, we have investigated novel acid-independent mechanisms by which these strains impair C. difficile virulence.
机译:背景艰难梭菌感染(CDI)是由于使用抗生素引起的,并导致严重的腹泻(艰难梭菌相关性腹泻,CDAD),这危及生命,且成本高昂。含有嗜酸乳杆菌CL1285,干酪乳杆菌LBC80R和鼠李糖乳杆菌CLR2(Bio-K +)的特定益生菌已证明具有预防CDI的优势,并对几种医院艰难梭菌菌株的体外生长具有很强的抑制作用。许多乳酸菌可通过乳酸酸化抑制CD的生长。在这里,我们研究了新的不依赖酸的机制,这些菌株通过这些机制损害艰难梭菌的毒力。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号